A Single Centre, Open Label Study to Characterize the PK-PDE10A Enzyme Occupancy Relationship of RO5545965 After a Single Dose in Healthy Male Volunteers Using [11C]IMA107 Positron Emission Tomography
Latest Information Update: 07 Nov 2021
At a glance
- Drugs RO 5545965 (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Roche
- 12 Nov 2013 New trial record